These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18508531)

  • 1. Multi-faceted roles for CXC-chemokines in prostate cancer progression.
    Waugh DJ; Wilson C; Seaton A; Maxwell PJ
    Front Biosci; 2008 May; 13():4595-604. PubMed ID: 18508531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
    Maxwell PJ; Neisen J; Messenger J; Waugh DJ
    Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.
    Gouwy M; Struyf S; Noppen S; Schutyser E; Springael JY; Parmentier M; Proost P; Van Damme J
    Mol Pharmacol; 2008 Aug; 74(2):485-95. PubMed ID: 18469140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
    Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
    Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
    J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion.
    Singh S; Singh UP; Grizzle WE; Lillard JW
    Lab Invest; 2004 Dec; 84(12):1666-76. PubMed ID: 15467730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXC chemokine receptor 4 expression and function in human astroglioma cells.
    Oh JW; Drabik K; Kutsch O; Choi C; Tousson A; Benveniste EN
    J Immunol; 2001 Feb; 166(4):2695-704. PubMed ID: 11160334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
    J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
    Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
    FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-chemokine-mediated signal transduction in human Kaposi's sarcoma spindle cells.
    Wang JF; Liu ZY; Anand AR; Zhang X; Brown LF; Dezube BJ; Gill P; Ganju RK
    Biochim Biophys Acta; 2004 May; 1691(2-3):129-39. PubMed ID: 15110993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice.
    Liu X; Peng J; Sun W; Yang S; Deng G; Li F; Cheng JW; Gordon JR
    Tohoku J Exp Med; 2012 Oct; 228(2):147-56. PubMed ID: 23019013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
    Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis.
    Wilson C; Purcell C; Seaton A; Oladipo O; Maxwell PJ; O'Sullivan JM; Wilson RH; Johnston PG; Waugh DJ
    J Pharmacol Exp Ther; 2008 Dec; 327(3):746-59. PubMed ID: 18780829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CXC chemokines and CXC chemokine receptors in orange-spotted grouper (Epinephelus coioides) and their expression after Singapore grouper iridovirus infection.
    Wang Q; Wang S; Zhang Y; Yu Y; Zhao H; Yang H; Zheng L; Yang M; Qin Q
    Dev Comp Immunol; 2019 Jan; 90():10-20. PubMed ID: 30165083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer.
    Baird AM; Gray SG; O'Byrne KJ
    PLoS One; 2011 Jan; 6(1):e14593. PubMed ID: 21298036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.
    Koizumi K; Hojo S; Akashi T; Yasumoto K; Saiki I
    Cancer Sci; 2007 Nov; 98(11):1652-8. PubMed ID: 17894551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration.
    Arya M; Ahmed H; Silhi N; Williamson M; Patel HR
    Tumour Biol; 2007; 28(3):123-31. PubMed ID: 17510563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of CXCL12 and CXCR4 in breast cancer.
    Luker KE; Luker GD
    Cancer Lett; 2006 Jul; 238(1):30-41. PubMed ID: 16046252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
    Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M
    Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.